Tuesday, May 15, 2018 12:59:58 PM
Kim D. Southworth, Chairman and CEO said, “We are excited Dr. James will be guiding the Company to evolve from a research development entity to an epigenetics business. The new Living Longevity Lab, founded by Dr. James, will deliver his high impact, life-changing, educational philosophy. BioAdaptives will continuously be expanding through the ever-evolving Living Longevity Lab. Dr. James will also build on the existing BioAdaptives’ research regarding stem cells, telomeres, and nootropics, to bring to market a unique, highly effective, proven product line.”
Southworth added, “Dr. James also successfully founded and built four companies in Media, Consumer Package Goods, and Nutraceuticals, all of which have gone on to generate millions of dollars in sales. BioAdaptives looks forward to a profitable and inspiring future under Dr. James’ direction.”
Dr. James commented, “Accepting the role of President and Founder of Living Longevity Lab is an honor and joy that I hold with unbridled enthusiasm and esteemed responsibility. Creating the Living Longevity Lab is an expression of my passion for community and human potential and performance. We have a unique and significant opportunity to bring our empowered mission and vision to a worldwide community that embraces the science of proactive lifestyle and the efficacy of research-driven products. Our dedicated and gifted team is aligned and poised to bring our love for serving and inspiring to lead an evolution and revolution in well-being to millions of seekers of ever-expanding longevity, vitality and life fulfillment.”
About BioAdaptives, Inc.
BioAdaptives, Inc. is a public company trading on OTC: PINK under the symbol BDPT. The company is engaged in research and development in science-based nutraceutical products for human and animal consumption.
SAFE HARBOR ACT
Forward-Looking Statements: This release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of BioAdaptives, Inc. and its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words "may," "would," "will," "expect," "estimate," "can," "believe," "potential" and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond BioAdaptives, Inc.'s ability to control, and actual results may differ materially from those projected in the forward-looking statements as a result of various factors. More information about the potential factors that could affect the business and financial results is and will be included in BioAdaptives, Inc.'s filings with the Securities and Exchange Commission.
A video accompanying this press release is available at:
http://www.globenewswire.com/NewsRoom/AttachmentNg/6d0504d8-bfdd-4627-81ce-4af745215fc4
SOURCE: BioAdaptives, Inc.
Investor Relations
BioAdaptives, Inc.
1-833-278-2378
ir@BioAdaptives.com
Original release at http://www.globenewswire.com/news-release/2018/05/15/1502690/0/en/BioAdaptives-Inc-Names-Dr-James-Rouse-as-President.html
John Galt is a fictional character from Atlas Shrugged, a 1957 novel by Ayn Rand.
*******************************************
My statements are my opinion. I may make predictions or share estimates or other information that might be considered a recomme
Recent BDPT News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:06:28 PM
- Form 1-A - Offering Statement [Regulation A] • Edgar (US Regulatory) • 10/11/2023 07:59:24 PM
- Form 1-Z - • Edgar (US Regulatory) • 08/24/2023 06:40:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:16:40 PM
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM